Partha Seshaiah

Partha Seshaiah is a highly experienced clinical study manager with a robust background in managing multi-site clinical studies for regulatory approval in pharmaceuticals and medical devices. Currently at Gala/Galvanize Therapeutics since October 2020, Partha previously held positions at Varian Medical Systems, where responsibilities included overseeing IDE and pre-market studies, and Dendreon Corporation as the Lead CRA for Phase IV therapy studies, successfully leading site start-up for over 50 locations. Partha's prior roles at Correlogic Systems, Inc. involved managing clinical research projects and coordinating multiple external CROs, while early career experience includes a research scientist role at CuraGen Corporation, delivering training on advanced genomic and proteomic technologies. Partha holds a Ph.D. in Biochemistry, Cellular and Molecular Biology from The Johns Hopkins University School of Medicine and a Bachelor's degree in Biology from the Massachusetts Institute of Technology.